FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2763665177> ?p ?o ?g. }

• W2763665177 abstract "e18546 Background: Primary goal in management of chronic myeloid leukemia (CML) is to prevent progression to BP-CML. Even with the use of induction chemotherapy with a TKI, outcome remains dismal in BP-CML. We describe our experience with the management of BP-CML. Methods: Retrospective chart review was performed on CML patients treated between 2001 and 2016. Out of 585 CML cases, 58 (10%) had a diagnosis of BP-CML. Kaplan-Meier method with log-rank test was utilized for survival calculations. All p-values calculated were two sided. Results: The overall survival (OS) of BP-CML cohort was 31.9 months (mo) from diagnosis. In the patients diagnosed in chronic or accelerated phase, median time to progression to BP-CML was 19.1 mo. The median OS from the BP-CML diagnosis was not different when progressed from an earlier phase compared toBP-CML (10.8 vs 11.0, p 0.62). Trend toward worse OS was noted in myeloid BP-CML compared to lymphoid BP-CML (9.2 vs 17.5 mo, p 0.32). The median OS in the single agent TKI cohort (n=21) was 12.8 mo vs 10.9 mo (p 0.72) in the combination cohort (n = 36). Treatment with a single agent TKI vs combination therapy did not significantly impact OS in either myeloid (9.2 vs 9.1 mo, p 0.32) or lymphoid (14.5 vs 18.3 mo, p 0.24) BP-CML. Out of 26 patients (44.8%) who received allogeneic stem cell transplant, 26% (n=6) received a single agent TKI prior to transplant and 76.9% (n=20) received combination therapy. A trend toward improved OS was noted in the single agent TKI cohort (128.5 vs 24.0 mo, p 0.23). When stratified by the presence of standard Philadelphia chromosome or with additional cytogenetic aberrations, no difference in OS was noted (10.9 vs 12.1 mo, p 0.51). Monosomy 7 was present in greater frequency in lymphoid BP-CML than myeloid BP-CML (35.7% vs 6.3%, p 0.02). Conclusions: Our data suggest no survival difference when BP-CML is treated with a single agent TKI compared to a combination therapy, regardless of histology type. Therefore, single agent TKIs should be considered as an effective frontline therapy option for BP-CML, which may prevent the potential toxicity associated with chemotherapy. These findings need further validation in a larger prospective cohort." @default.
• W2763665177 created "2017-10-20" @default.
• W2763665177 creator A5025137989 @default.
• W2763665177 creator A5028386440 @default.
• W2763665177 creator A5047764826 @default.
• W2763665177 creator A5057933586 @default.
• W2763665177 creator A5060360947 @default.
• W2763665177 creator A5068140925 @default.
• W2763665177 creator A5078822704 @default.
• W2763665177 creator A5084789778 @default.
• W2763665177 date "2017-05-20" @default.
• W2763665177 modified "2023-09-26" @default.
• W2763665177 title "Outcomes of blast phase chronic myeloid leukemia (BP-CML) in the tyrosine kinase inhibitor (TKI) era." @default.
• W2763665177 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.e18546" @default.
• W2763665177 hasPublicationYear "2017" @default.
• W2763665177 type Work @default.
• W2763665177 sameAs 2763665177 @default.
• W2763665177 citedByCount "1" @default.
• W2763665177 countsByYear W27636651772020 @default.
• W2763665177 crossrefType "journal-article" @default.
• W2763665177 hasAuthorship W2763665177A5025137989 @default.
• W2763665177 hasAuthorship W2763665177A5028386440 @default.
• W2763665177 hasAuthorship W2763665177A5047764826 @default.
• W2763665177 hasAuthorship W2763665177A5057933586 @default.
• W2763665177 hasAuthorship W2763665177A5060360947 @default.
• W2763665177 hasAuthorship W2763665177A5068140925 @default.
• W2763665177 hasAuthorship W2763665177A5078822704 @default.
• W2763665177 hasAuthorship W2763665177A5084789778 @default.
• W2763665177 hasConcept C121608353 @default.
• W2763665177 hasConcept C126322002 @default.
• W2763665177 hasConcept C143998085 @default.
• W2763665177 hasConcept C170493617 @default.
• W2763665177 hasConcept C2777413986 @default.
• W2763665177 hasConcept C2777583451 @default.
• W2763665177 hasConcept C2778729363 @default.
• W2763665177 hasConcept C2778820342 @default.
• W2763665177 hasConcept C2779536868 @default.
• W2763665177 hasConcept C42362537 @default.
• W2763665177 hasConcept C502942594 @default.
• W2763665177 hasConcept C71924100 @default.
• W2763665177 hasConceptScore W2763665177C121608353 @default.
• W2763665177 hasConceptScore W2763665177C126322002 @default.
• W2763665177 hasConceptScore W2763665177C143998085 @default.
• W2763665177 hasConceptScore W2763665177C170493617 @default.
• W2763665177 hasConceptScore W2763665177C2777413986 @default.
• W2763665177 hasConceptScore W2763665177C2777583451 @default.
• W2763665177 hasConceptScore W2763665177C2778729363 @default.
• W2763665177 hasConceptScore W2763665177C2778820342 @default.
• W2763665177 hasConceptScore W2763665177C2779536868 @default.
• W2763665177 hasConceptScore W2763665177C42362537 @default.
• W2763665177 hasConceptScore W2763665177C502942594 @default.
• W2763665177 hasConceptScore W2763665177C71924100 @default.
• W2763665177 hasLocation W27636651771 @default.
• W2763665177 hasOpenAccess W2763665177 @default.
• W2763665177 hasPrimaryLocation W27636651771 @default.
• W2763665177 hasRelatedWork W1540169648 @default.
• W2763665177 hasRelatedWork W1558010710 @default.
• W2763665177 hasRelatedWork W1562505275 @default.
• W2763665177 hasRelatedWork W1563524764 @default.
• W2763665177 hasRelatedWork W2011721114 @default.
• W2763665177 hasRelatedWork W2405602156 @default.
• W2763665177 hasRelatedWork W2514933712 @default.
• W2763665177 hasRelatedWork W2761675969 @default.
• W2763665177 hasRelatedWork W2888987138 @default.
• W2763665177 hasRelatedWork W2889302155 @default.
• W2763665177 hasRelatedWork W2897425292 @default.
• W2763665177 hasRelatedWork W2961215402 @default.
• W2763665177 hasRelatedWork W2971348717 @default.
• W2763665177 hasRelatedWork W3009515890 @default.
• W2763665177 hasRelatedWork W3029211490 @default.
• W2763665177 hasRelatedWork W3030559716 @default.
• W2763665177 hasRelatedWork W3030807518 @default.
• W2763665177 hasRelatedWork W3088741134 @default.
• W2763665177 hasRelatedWork W3118388093 @default.
• W2763665177 hasRelatedWork W3137154050 @default.
• W2763665177 isParatext "false" @default.
• W2763665177 isRetracted "false" @default.
• W2763665177 magId "2763665177" @default.
• W2763665177 workType "article" @default.